A TLR and CLR Agonist Combination Induces Anti-Tumor Immunity against Peritoneal Carcinomatosis
Year: 2019
Type: dissertation
Abstract: Peritoneal carcinomatosis (PC) is a condition where primary tumors metastasize into the peritoneal cavity and induce malignant ascites. One strategy currently being explored to treat malignancies involves leukocyte activation through pattern recognition receptors (PRRs), including Toll-Like Receptors (TLRs) and C-type Lectin Receptors (CLRs). Our data shows that mice treated with a TLR and CLR agonist combination are afforded significant protection when challenged with an aggressive ascites-forming mammary tumor cell line (TA3-Ha). However, when mice lack B-1a cells, the protection is lost. Activated, antibody-secreting cells (ASCs) are found in the spleen, peritoneal cavity and visceral adipose tissue (VAT). Consistent with ASC differentiation, the treatment induces a significant increase in IgM and complement (C’) bound to tumor cells, both of which are critical components in the antitumor effect.
Author: Dyevoich, Allison
Institution: Wake Forest University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W6987659442
